FLC testing in multiple myeloma and kidney disease: A Chinese Perspective

Multiple myeloma (MM) is one of the most common blood cancers, often involving impaired kidney function. Free light chains (FLC) testing is a guideline-recommended cornerstone in the diagnosis, monitoring, and disease management of MM. This session explores the current role of FLC testing in MM, and considers the influence of kidney function on FLC test result. Dr. Mao Yonghui shares a Chinese perspective on this important subject.

Mao Yonghui, Beijing Hospital

Dr. Mao Yonghui
Dept. of Nephrology
Beijing Hospital, China